Cord Blood America CEO Update

Cord Blood America CEO Updates Investors on Financial Developments and Stem Cell News in Interview

LAS VEGAS, Aug. 25, 2010 - PRNewswire-FirstCall. Cord Blood America, Inc (OTC Bulletin Board: CBAI.ob - News), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that CEO Matt Schissler was interviewed recently by Tom Allinder of InBoundMarketingPR.

During the course of the interview, Mr. Schissler discussed contents of recent financially related news releases – retirement of the $1.1 million debt obligation with JMJ Financial on 5 August, 2010 and details from the 18 August, 2010 news release detailing the company's quarterly earnings. Mr. Schissler also discusses recent news that a federal judge temporarily blocked the Obama administration Monday from using federal dollars to fund expanded human embryonic stem cell research and how the news impacts Cord Blood America. The interview is accessible atInBoundMarketingPR.com.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at www.corcell.com. For investor information, visitwww.cordblood-america.com.

CONTACT:
Paul Knopick
E & E Communications
949-707-5365
pknopick@eandecommunications.com